26. Aug 2026
Description
(AWP Alliance News) - Lonza Group Ltd - Basel, Switzerland-based contract development and manufacturing organisation focused on serving the healthcare industry - Announces appointment of Samanta Cimitan to serve in the newly created role of chief commercial officer from January 1 onwards. Cimitan currently serves as chief executive officer at Celonic AG, a Basel-based biologics CDMO firm. In her new position, Cimitan will lead strategic enterprise account management, global marketing and commercial excellence.
Lonza CEO Wolfgang Wienand says: "Samanta brings deep CDMO expertise, commercial leadership experience and first-hand knowledge of Lonza. She understands what it takes to build trusted partnerships, execute with commercial discipline and create value across the full development and manufacturing journey."
Current stock price: CHF593.80
12-month change: up 2.7%
By Elijah Dale, Alliance News senior reporter Asia-Pacific
Comments and questions to newsroom [at] alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.